These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9306965)

  • 1. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features.
    Dal Cin P; Sciot R; Panagopoulos I; Aman P; Samson I; Mandahl N; Mitelman F; Van den Berghe H; Fletcher CD
    J Pathol; 1997 Aug; 182(4):437-41. PubMed ID: 9306965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
    Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
    Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
    Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
    Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.
    Panagopoulos I; Lassen C; Isaksson M; Mitelman F; Mandahl N; Aman P
    Oncogene; 1997 Sep; 15(11):1357-62. PubMed ID: 9315104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
    Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
    Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
    Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
    Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
    Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J
    Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma.
    Panagopoulos I; Aman P; Mertens F; Mandahl N; Rydholm A; Bauer HF; Mitelman F
    Genes Chromosomes Cancer; 1996 Oct; 17(2):102-7. PubMed ID: 8913727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
    Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
    Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
    Crozat A; Aman P; Mandahl N; Ron D
    Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel FUS/CHOP chimera in myxoid liposarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Mandahl N
    Biochem Biophys Res Commun; 2000 Dec; 279(3):838-45. PubMed ID: 11162437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel type of EWS-CHOP fusion gene in myxoid liposarcoma.
    Matsui Y; Ueda T; Kubo T; Hasegawa T; Tomita Y; Okamoto M; Myoui A; Kakunaga S; Yasui N; Yoshikawa H
    Biochem Biophys Res Commun; 2006 Sep; 348(2):437-40. PubMed ID: 16884691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21).
    Panagopoulos I; Mandahl N; Mitelman F; Aman P
    Oncogene; 1995 Sep; 11(6):1133-7. PubMed ID: 7566973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma.
    Rabbitts TH; Forster A; Larson R; Nathan P
    Nat Genet; 1993 Jun; 4(2):175-80. PubMed ID: 7503811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxoid liposarcoma with EWS-CHOP type 1 fusion gene.
    Suzuki K; Matsui Y; Endo K; Kubo T; Hasegawa T; Kimura T; Ohtani O; Yasui N
    Anticancer Res; 2010 Nov; 30(11):4679-83. PubMed ID: 21115923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications.
    Willeke F; Ridder R; Mechtersheimer G; Schwarzbach M; Duwe A; Weitz J; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Clin Cancer Res; 1998 Jul; 4(7):1779-84. PubMed ID: 9676855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice.
    Pérez-Losada J; Pintado B; Gutiérrez-Adán A; Flores T; Bañares-González B; del Campo JC; Martín-Martín JF; Battaner E; Sánchez-García I
    Oncogene; 2000 May; 19(20):2413-22. PubMed ID: 10828883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.
    Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA
    J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
    Kuroda M; Ishida T; Takanashi M; Satoh M; Machinami R; Watanabe T
    Am J Pathol; 1997 Sep; 151(3):735-44. PubMed ID: 9284822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
    Prasad DD; Ouchida M; Lee L; Rao VN; Reddy ES
    Oncogene; 1994 Dec; 9(12):3717-29. PubMed ID: 7970732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.